Oliver Hantschel

15PUBLICATIONS
70CO-AUTHORS
Haematological tumoursBiomolecular modelling and designMolecular targetsTumour immunologyInorganic materials (incl. nanomaterials)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.

|Dec 23, 2024
Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase.

Nina Schmidt, Amit Kumar, Lukas Korf

|Apr 21, 2024
BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.

Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis

|Aug 17, 2022
Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl.

Nina Schmidt, Frank Abendroth, Olalla Vázquez

|Sep 23, 2021
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.

Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola

|Jun 22, 2021
Tuning SAS-6 architecture with monobodies impairs distinct steps of centriole assembly.

Georgios N Hatzopoulos, Tim Kükenshöner, Niccolò Banterle

Pageof 3

Frequent Collaborators

2 joint publications

Shohei Koide

2 joint publications

Inga B Leske

2 joint publications

Florence Pojer

2 joint publications

Nina Schmidt